Viewing Study NCT00243035


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-02-28 @ 9:05 PM
Study NCT ID: NCT00243035
Status: TERMINATED
Last Update Posted: 2013-10-08
First Post: 2005-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module